Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

 

PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has release. preliminary data* from its first 50 cases.

 

 

The registry has received cases from all over the world in its first few weeks of operation.

 

The aim of PsoProtect is to better our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis.

 

 

In addition to demographics, PsoProtect collects the following types of de-identified data:

  • Psoriasis disease characteristics, comorbidities and systemic treatment for psoriasis at onset of COVID-19
  • COVID-19 characteristics and disease course
  • COVID-19 outcome

We encourage clinicians to continue reporting cases of COVID-19 (suspected or confirmed) in psoriasis via the simple online PsoProtect case report form.

 

*Data are preliminary and include a limited number of cases and should not be used to inform clinical decision making.

 

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK